Josh Disbrow

Chief Executive Officer

About Me

Josh Disbrow, a resident of Denver, CO, stands as a distinguished luminary within the pharmaceutical industry, boasting an extensive and diverse quarter-century experience spanning pharmaceuticals, diagnostics, and medical devices. His professional journey is marked by the triumphant founding and establishment of Aytu BioPharma, which has flourished remarkably under his guidance, alongside noteworthy contributions to other prominent pharmaceutical entities. Beyond his professional accomplishments, Josh's persona is illuminated by his deep-rooted familial ties, musical inclinations, and genuine commitment to philanthropy. Josh steers the ship with visionary leadership as the Chief Executive Officer and Board Director of Aytu BioPharma, a company he co-founded in 2015. Under his guidance, Aytu BioPharma achieved a significant milestone by securing a listing on NASDAQ in 2017, surpassing $100 million in annual revenues within seven years. His strategic prowess is further showcased through the orchestration of four company acquisitions in under four years, solidifying the company's growth trajectory.

Furthermore, as a Director at Zynex, Inc., a publicly-listed medical device firm specializing in electrotherapy and pain management, Josh assumes a leadership role as a board member. His commitment to corporate governance is exemplified through his Nominating and Governance Committee chairmanship. Josh's career journey commenced as a sales representative at Glaxo Wellcome (now GlaxoSmithKline plc). His upward trajectory led him to pivotal roles in commercial and leadership capacities at esteemed institutions such as Cyberonics, LipoScience, Arbor Pharmaceuticals, and Ampio Pharmaceuticals. An apex of his career was his transformative role at Arbor, where he catalyzed the company's evolution from pre-commercialization to amassing over $250 million in revenue within a remarkable five-year span.

Learn More


Josh Disbrow - Portfolio

Recent News

Josh Disbrow
December 13, 2023

Unveiling the Nexus Exploring Crucial Facets of Pharmaceutical Alliances

In the intricate tapestry of pharmaceuticals, the interplay between innovation and collaboration is a dynamic force that propels the industry forward. As companies embark on the journey of forging alliances through licensing and partnerships, a nuanced understanding of pivotal considerations becomes the compass for navigating this complex terrain. This article delves into the core facets […]

October 16, 2023

Effective Strategies for Pharmaceutical Sales and Marketing

In the dynamic and highly regulated pharmaceutical industry, effective sales and marketing strategies are paramount to success. These strategies not only require an in-depth understanding of the products but also the ability to navigate a complex landscape of regulations and competition. In this article, we will explore the essential strategies that pharmaceutical companies can employ […]

September 21, 2023

Goose, Panic, and Greensky: A Fan’s Guide to Eclectic Musical Adventures

In the vibrant world of live music and jam bands, there are a few names that stand out as pioneers of the genre, known for their improvisational prowess and diverse musical influences. Among these trailblazers are Goose, Widespread Panic, and Greensky Bluegrass. If you’re a fan of eclectic musical adventures, these bands offer an unparalleled […]

September 7, 2023

Navigating the Future: Trends in Pharmaceutical Start-ups and Innovation

The pharmaceutical industry has always been a hotbed of innovation, driven by the constant pursuit of breakthroughs in medical science. In recent years, however, the landscape of pharmaceutical innovation has undergone a remarkable transformation, largely fueled by a surge in pharmaceutical start-ups. These nimble and agile companies are changing the game, challenging established giants, and […]

Get In Touch